Merck and Co. (Whitehouse Station, NJ) has entered into an agreement with the biotechnology company C Sixty (Houston, TX) for the development and commercialization of C Sixty's fullerene antioxidant technology.
The top 16 U.S. pharmaceutical companies spend more than $90 billion on manufacturing each year, according to a Wall Street Journal article released 3 September 2003.
The European Union has introduced new legislation designed to encourage pharmaceutical companies to develop treatments for "orphan" (rare) diseases that affect fewer than five people in every 10000 within the 15 member bloc.
In the face of bad publicity and impending restrictions,
trade groups representing pharmaceutical companies have
proposed a voluntary plan for using a clinical trials
registry as well as results databases by midyear.
[Australia] has more things that will kill you than anywhere
else.... This is a country where even the fluffiest of
caterpillars can lay you out with a toxic nip, where seashells
will not just sting you but actually sometimes gofer you....
It's a tough place.
The mood among exhibitors at this year's Informex trade
show in Las Vegas was the brightest it has been in several
years. Although 2005 looks like it will deliver slight
improvement from the ugliness of the first years of the
decade, manufacturers of active pharmaceutical ingredients
(APIs) are looking for a return to real profitability
in 2006.
Even though trademark legislation does not specifically
address the needs of the pharmaceutical industry, there
are unique rules governing the nomenclature, nonproprietary
naming, and trademark choice of pharmaceuticals.
